[1] |
SUN Qiyue, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing.
Safe doses of Lingyang Ganmao oral liquid for children based on the multi-animal model
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 121-126.
|
[2] |
LIU Wendong, CUI Huanhuan, WANG Xiaohan, SU Xian, WANG Haixue.
Status and thinking of Parmacovigilance regulatory system during clinical trials of the pediatric drug in China
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1002-1006.
|
[3] |
TAI Jun, YU Miao, ZHANG Lin, LEI Yi, LIU Junting, LI Tao, HUANG Guimin, CHENG Yijing, NIE Xiaolu, WANG Qing.
Active monitoring of adverse reactions related to haemocoagulase agkistrodon for injection in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1011-1016.
|
[4] |
.
Annual report of national adverse drug reaction monitoring (2022)
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 712-719.
|
[5] |
ZHAO Yan, LIU Wenbo, ZHAO Yifei, LI Dong, ZHENG Lijia, SONG Yana, ZHAO Yujuan, DONG Fang.
Applicability of patient registry research to regulation of medical devices
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 423-427.
|
[6] |
ZHANG Zhiqi, GUO Mingxing, XU Ye, ZHANG Jian, LIN Jun, CUI Xiangli.
One case of tacrolimus-caused reversible posterior leukoencephalopathy syndrome after renal transplantation in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 465-468.
|
[7] |
DU Ying, XIE Yanming, WANG Lianxin, GENG Hongjiao, LI Xiangjie.
Clinical characteristics and drug combination analysis of Lianhua Qingwen capsules (granules) in the real world
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 296-300.
|
[8] |
JIA Zhaoguang, XU Wenshuai, JI Li’na, WANG Linlin, ZHAO Li’na, ZHAO Jingquan, MU Xiangdong.
Diagnosis and treatment of mycoplasma pneumoniae pneumonia in children and rational administration of related drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1391-1395.
|
[9] |
PENG Jing, TUO Yali, LI Qiaoling, ZHOU Rong, LI Xinlin, PENG Hui.
Data analysis of adverse events of clobazam among children based on foreign pharmacovigilance safety spontaneous reporting system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1264-1268.
|
[10] |
WU Yunxiao, YU Yuelin, WANG Shengfeng, SUN Feng, MENG Ruogu, ZHAN Siyan.
Suitability assessment of real-world data in active post-marketing surveillance of vaccine safety
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1081-1089.
|
[11] |
CAO Xiaoyu, WANG Ying, WANG Jingwen, YANG Ruixia, GE Jie.
Analysis of agranulocytosis in a child induced by vancomycin injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 106-109.
|
[12] |
SU Xinxin, ZHAO Xiaoxiao, XIE Yanming.
Real-world analysis of combined administration of elemene emulsion injection in patients with liver cancer
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 929-934.
|
[13] |
ZHANG Jingyu, ZHANG Yuanyuan, WANG Jing, MA Bo, LI Wenjuan.
Influencing factors of severe anaphylactic reactions of Yanhuning injections in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1019-1022.
|
[14] |
XUN Xiaoqing, PENG Lingling.
Effects of sodium valproate on children with epilepsy and determinants of blood concentrations
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1027-1029.
|
[15] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|